Helios 5.8 mg

Dragon Pharma Helios

Helios is a specialized injectable fat loss compound developed by Dragon Pharma, combining two well-known thermogenic agents: clenbuterol hydrochloride and yohimbine hydrochloride. This combination is designed to support fat reduction during cutting phases, particularly in stubborn areas where fat loss tends to be slower.

Unlike many traditional fat loss compounds, Helios is commonly administered through localized subcutaneous injections. This delivery method is popular among experienced athletes and physique competitors who aim to target specific areas such as the lower abdomen, flanks, or thighs while maintaining overall conditioning.

The clenbuterol component acts as a beta-2 adrenergic agonist that stimulates metabolic activity and increases thermogenesis, which may help the body utilize stored fat as energy. Yohimbine works through alpha-2 receptor antagonism, a mechanism associated with mobilizing fat deposits that are often resistant to dieting and cardio alone.

Together, these compounds form a synergistic blend that many athletes incorporate during the final stages of a cutting program. Helios is often used alongside structured nutrition, cardiovascular training, and compounds commonly included in physique preparation cycles.

Many users combine Helios with other Dragon Pharma cutting agents such as Clenbuterol or metabolic support compounds like GW501516 during advanced cutting phases. In physique competition preparation, it may also be stacked with lean hardening compounds such as Masteron 100 to support a dry and defined appearance.

Dragon Pharma manufactures Helios using pharmaceutical-grade raw materials and strict production standards, helping ensure consistency, purity, and reliable dosing in each vial.

Key Benefits:

• Cutting Support: Designed to complement structured fat-loss phases.
• Thermogenic Activity: Clenbuterol component increases metabolic stimulation.
• Targeted Application: Often used for localized fat reduction strategies.
• Physique Conditioning: Popular among athletes preparing for lean stages.
• Dual-Compound Formula: Combines two complementary fat-mobilizing agents.

Each vial contains a balanced blend of clenbuterol HCl and yohimbine HCl suspended in MCT oil, manufactured under strict quality control standards in Dragon Pharma's certified facilities.

Product Specifications

Usage Guidelines

Helios is typically used during cutting cycles where reducing body fat while maintaining muscle definition is a priority. Because it is administered via subcutaneous injection, proper technique and hygiene are essential.

• Beginner Cycle: 0.5 mL once daily for 4–6 weeks.
• Intermediate Cycle: 0.5–1 mL daily for 6–8 weeks depending on tolerance.
• Advanced Cycle: 1 mL daily combined with advanced cutting stacks.

Helios is frequently stacked with fat loss or endurance compounds such as Aicar or metabolic enhancers like L-Carnitine. In advanced contest preparation phases, some athletes also combine it with Trenbolone 100 for enhanced physique conditioning.

Post Cycle Therapy (PCT):

Helios does not suppress natural testosterone production and therefore does not require traditional post-cycle therapy.

Liver Protection:

As Helios is not hepatotoxic, liver protection supplements are typically unnecessary. However, maintaining adequate hydration and balanced nutrition is recommended during cutting cycles.

Third-Party Lab Tested

2025-11-20

View Result

43.28 mcg/5.27 mg

Storage Instructions

Store Helios in a cool, dry environment away from direct sunlight. Keep the vial sealed when not in use and maintain proper sterile handling practices to preserve product stability.